Prana Biotechnology Limited (NASDAQ:PRAN)’s stock price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.00 and traded as high as $1.02. Prana Biotechnology shares last traded at $0.95, with a volume of 16,782 shares traded.
The stock has a market cap of $8.46 million, a price-to-earnings ratio of -1.36 and a beta of 1.05. The firm has a fifty day moving average price of $1.23.
Prana Biotechnology Company Profile (NASDAQ:PRAN)
Prana Biotechnology Limited researches and develops therapeutic drugs for the treatment of Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidates include PBT434 that is in Phase I clinical trial for the treatment for Parkinson's disease and other movement disorders; and PBT2, which has completed four Phase I studies and a Phase IIa clinical trial for patients with Alzheimer's disease.
Further Reading: Strike Price
Receive News & Ratings for Prana Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prana Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.